Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Psoriasis × Adalimumab × Clear all

Status

Sponsor Class

Study Type

Interventional 3 Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 6 Spondylitis, Ankylosing 1 Psoriasis 1 Inflammatory Bowel Diseases 1 Infections 1 Arthritis, Psoriatic 1

Interventions

deucravacitinib 2 purine 1 fumaric acid 1 apremilast 1 Sulfasalazine 1 Standard of Care 1 Practice Guidelines as Topic 1 Methotrexate 1 Methods 1 Mesalamine 1 Mercaptopurine 1 Interviews as Topic 1 Infliximab 1 Etanercept 1 Educational Status 1 Eating 1 Early Intervention, Educational 1 Dietary Fiber 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02376478 2015-03-03

On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

Medical University of Vienna

Psoriasis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡